$AVXL

$1.15▲ +0.9% YTD

8 SEC 13D/G filings tracked · Last updated Nov 3, 2026

Filing History

AVXL ▲ +0.9% - Anavex Life Sciences Corp.

CP $1.15▲ +0.9%Nov 3, 2026 · ThinkSabio Blog

$AVXL - Anavex Life Sciences Names Terrie Kellmeyer, Ph.D., as President and Chief Executive Officer and Member of the Board of Directors…

News

AVXL ▲ +10.4% - Anavex Life Sciences Corp.

CP $1.38▲ +10.4%Oct 20, 2026 · ThinkSabio Blog

$AVXL - Anavex Provides Corporate Update, Announces Completion of Clinical Conduct of ADME and DDI Clinical Studies…

News

AVXL ▲ +6.7% - Anavex Life Sciences Corp.

CP $1.60▲ +6.7%Oct 15, 2026 · ThinkSabio Blog

$AVXL - Anavex Receives FDA Clearance of its IND Application for Blarcamesine in Fragile X Syndrome…

News

AVXL ▼ -2.1% - Anavex Life Sciences Corp.

CP $2.29▲ -2.1%Sep 24, 2026 · ThinkSabio Blog

$AVXL - Anavex Stockholders Elect All of the Company’s Director Nominees at 2026 Annual Meeting…

News

AVXL ▲ +0.4% - Anavex Life Sciences Corp.

CP $2.63▲ +0.4%Sep 14, 2026 · ThinkSabio Blog

$AVXL - Leading Independent Proxy Advisory Firm ISS Recommends Stockholders Vote “FOR” All Six of Anavex’s Highly Qualified Director Nominees…

News

AVXL ▼ -1.7% - Anavex Life Sciences Corp.

CP $2.81▲ -1.7%Sep 8, 2026 · ThinkSabio Blog

$AVXL - Anavex Life Sciences to Host Investor Call on Wednesday, September 9, 2026, at 4:00 PM ET…

News

AVXL ▲ +0.7% - Anavex Life Sciences Corp.

CP $2.89▲ +0.7%Sep 2, 2026 · ThinkSabio Blog

$AVXL - Anavex Life Sciences Regains Compliance with Nasdaq Periodic Filing Requirement…

SEC 13D/G

$AVXL SEC Filing Update (31-JUL-2026) | ThinkSabio - Stocks Simplified

$2.70▼ -26.83%Jul 31, 2026 · ThinkSabio Blog

$AVXL SEC 13D/G institutional ownership filing. Healthcare sector. SEC Filing Update: #AVXL : $2.70 Sector: Healthcare | YTD: 🔽 -26.83% The SEC disclo…